Skip to main content

Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer Cover

.blurhash-client-img { display: none !important; }

Secondary Hodgkin Lymphoma and Myelodysplastic Syndrome (MDS) After Paclitaxel-Carboplatin Treatment in a Patient with Small Cell Lung Cancer

Volume 38 (2017): Issue 3 (December 2017)

By: Marija Petrusevska, Irina Panovska Stavridis, Kristina Mladenovska and Gordana Petrushevska

Open Access

|Apr 2018

Full Article

Abbreviations

SCLC: -small cell lung cancer
ABVD: -adriamycin, bleomycin, vinblastine, dacarbazine
RBC: – red blood cell
WBC: – white blood cell
HGB: - hemoglobin
HCT: - hematocrit
PLT: - platelets
AST: – aspartate aminotransferase
ALT: – alanine transaminase
MDS: - myelodysplastic syndrome
ALIP: - abnormal localization of immature precursors

Articles in this issue

DOI: https://doi.org/10.2478/prilozi-2018-0010 | Journal eISSN: 1857-8985 (formerly 0350-1914) | Journal ISSN: 1857-9345

Journal RSS Feed

Language: English

Page range: 97 - 103

Published on: Apr 16, 2018

Published by: Macedonian Academy of Sciences and Arts

In partnership with: Paradigm Publishing Services

Publication frequency: 3 issues per year

Keywords:

Hodgkin lymphoma,

Castleman disease paclitaxel,

Related subjects:

Social sciences,

Education, other

© 2018 Marija Petrusevska, Irina Panovska Stavridis, Kristina Mladenovska, Gordana Petrushevska, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 38 (2017): Issue 3 (December 2017)

Previous article